(Total Views: 474)
Posted On: 11/03/2025 11:03:10 AM
Post# of 158789
"The only anecdote is clinical trials, data, and anonymous donors and funders, which is the correct course and the course the company is pursuing."
You can now add to that list above a well-known privately held Global Investment Firm, Yorkville Advisers. Well done Huffman and CytoDyn team. You have now been admitted to the big boy's tent.
In the words of Dr J, "“Leronlimab’s ability to induce an inflamed or “hot” tumor environment, that could then be treated with ICIs, would be a game changer in solid tumor oncology. Prospectively confirming these findings...is a top priority.
Do your own due diligence but my conviction is stronger than ever. We now have additional non-dilutive funding. And after confirmation of the miracle molecule, we will be in open waters and Dr J will be charting the most beneficial course for patients and investors.
Keep on keeping on and staying long for the long haul
KOKO&SLLH
You can now add to that list above a well-known privately held Global Investment Firm, Yorkville Advisers. Well done Huffman and CytoDyn team. You have now been admitted to the big boy's tent.
In the words of Dr J, "“Leronlimab’s ability to induce an inflamed or “hot” tumor environment, that could then be treated with ICIs, would be a game changer in solid tumor oncology. Prospectively confirming these findings...is a top priority.
Do your own due diligence but my conviction is stronger than ever. We now have additional non-dilutive funding. And after confirmation of the miracle molecule, we will be in open waters and Dr J will be charting the most beneficial course for patients and investors.
Keep on keeping on and staying long for the long haul
KOKO&SLLH
(4)
(0)
